ClinicalTrials.gg
Not yet recruitingNCT07031960Updated Jun 22, 2025

3D Eye Movement Simulator for Medical Education

An interventional study of 3D Eyeball Movement Simulator Group and Conventional Teaching Methods Group in Education, Education, Medical, Undergraduate and Education, Medical, sponsored by Isfahan University of Medical Sciences. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-06-22.

Sponsored by Isfahan University of Medical Sciences · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether a new 3D-printed eyeball movement simulator improves medical education compared to traditional teaching methods. The main questions it aims to answer are:

Does using the 3D simulator help medical students better understand eye anatomy and muscle function compared to standard lectures and textbooks?

How do students rate the usability and effectiveness of this new teaching tool?

Researchers will compare two groups of medical students:

One group will learn using the 3D simulator

The other group will receive standard teaching methods

Participants will:

  1. Complete a pre-test to assess their baseline knowledge
  2. Attend training sessions using either the 3D simulator or standard methods
  3. Take a post-test to measure learning improvement
  4. Provide feedback about their learning experience
  5. Take a post-intervention exam and satisfaction survey
  6. Participate in focus groups about their learning experience

The study will help determine if interactive 3D models can enhance medical education about eye movements.

02

Conditions studied

  • Education
  • Education, Medical, Undergraduate
  • Education, Medical

Keywords

  • medical education
  • 3D model
  • eye movement
03

In context

Lead sponsor

Isfahan University of Medical Sciences is the lead sponsor of 150 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Academic Status Currently enrolled medical students in their preclinical years (typically 2nd-3 year)"
  2. Course Enrollment "Formally registered in the special scence/anatomy course where eye movement education is part of the curriculum"

Prior Experience "No previous formal training in extraocular muscle anatomy or eye movement assessment"

Language Proficiency "Fluent in the language of instruction (Farsi)"

Consent "Willing and able to provide "

Exclusion criteria

Exclusion Criteria:

1- Prior Exposure "Medical students who have previously taken advanced special scence courses"

Professional Experience "Students with prior clinical experience in ophthalmology ( as nurses or technicians)"

Atypical Curriculum "Students from schools with non-standard anatomy curricula that already include similar 3D simulation tools"

Participation Conflicts "Currently participating in other educational research studies that could confound results"

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    3D Eyeball Movement Simulator Group

    Arm 1 (Experimental Group): Participants in this arm will use an interactive 3D-printed simulator that physically replicates human eyeball movements and extraocular muscle function. This hands-on educational tool allows medical students to manipulate the model and observe biomechanical principles of eye movements in real-time.

    Device: 3D Eyeball Movement Simulator Group

  • Active comparator
    Conventional Teaching Methods Group

    Participants in this arm will receive standard anatomy instruction through traditional methods including didactic lectures, 2D textbook illustrations, and static anatomical models - representing the current typical curriculum for ophthalmic anatomy education.

    Other: Conventional Teaching Methods Group

Interventions

  • Device3D Eyeball Movement Simulator Group

    A physical, interactive 3D-printed educational model that replicates human eyeball movements and demonstrates the biomechanical action of extraocular muscles. The simulator allows hands-on manipulation to demonstrate all cardinal eye movements (adduction, abduction, elevation, depression, intorsion, and extorsion) through mechanical actuation of synthetic muscle analogues."

  • OtherConventional Teaching Methods Group

    Standard medical education methods for teaching eye anatomy and movements, including: (1) didactic classroom lectures with 2D illustrations, (2) static anatomical models of the orbit and eyeball, and (3) textbook-based learning materials. This represents the current conventional approach to teaching this content in medical curricula

06

What researchers measure

Primary outcomes

  1. Knowledge Gain Score

    Difference in test scores between pre-intervention and post-intervention assessments on eye anatomy and movement kinematics, measured using a validated 50-point multiple-choice questionnaire

    Time frame: Baseline (pre-intervention), Immediately after intervention (1 day post-training)

Secondary outcomes

  1. Skill Acquisition in Eye Movement Assessment

    Performance in practical examination where students identify and demonstrate eye movements on standardized patients, scored by blinded evaluators using a 12-point checklist.

    Time frame: "Baseline" or "Day 1"

  2. Student Satisfaction Scores

    Participant-reported satisfaction with the teaching method measured via 5-point Likert scale survey (1=very dissatisfied to 5=very satisfied).

    Time frame: Immediately post-intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2025; primary completion for Jun 2025, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2025
First posted
Jun 22, 2025
StartEst.
Jun 15, 2025
Primary completionEst.
Jun 30, 2025
CompletionEst.
Aug 20, 2025
Last update
Jun 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07031960
Responsible party
mehrnoush malekzadeh (Assistant Professor, Isfahan University of Medical Sciences) — Principal investigator
First posted
Jun 22, 2025
Start date
Jun 15, 2025 (estimated)
Primary completion
Jun 30, 2025 (estimated)
Completion
Aug 20, 2025 (estimated)
Last update
Jun 22, 2025

Study contacts

Mehrnoush Malekzadeh, Ph.D
Contact
mehrnoush.malekzadeh@med.mui.ac.ir
09133097258

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion